Literature DB >> 527599

A fluorometric method for the determination of praziquantel in blood-plasma and urine.

J Pütter.   

Abstract

Some physicochemical data of praziquantel which may have analytical relevance are reported. For the quantitative determination praziquantel is extracted from plasma or urine by means of organic solvents and then hydrolyzed in an aqueous alkaline solution. The hydrolyzed product is reacted with dansyl-chloride (5-dimethylaminonaphthalene-sulfonylchloride). The dansylated compound is separated and quantified fluorometrically. The limit of determination is 3 micrograms/l in blood plasma and 30 micrograms/d in urine. For both fluids, the imprecision is approximately 7.5%. The method is suitable for the determination of praziquantel in patients or healthy volunteers treated with therapeutic doses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527599     DOI: 10.1007/BF03189417

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  4 in total

1.  The International Federation of Clinical Chemistry. IFCC Section no. 3. Provisional Recommendation on quality control in clinical chemistry. Part 1. General Principles and Terminology (Stage 2, Draft 2).

Authors:  N E Saris
Journal:  Z Klin Chem Klin Biochem       Date:  1975-11

2.  The efficacy of praziquantel against cestodes in animals.

Authors:  H Thomas; R Gönnert
Journal:  Z Parasitenkd       Date:  1977-07-21

3.  Serum concentrations and renal excretion in humans after oral administration of praziquantel--results of three determination methods.

Authors:  K Patzschke; J Pütter; L A Wegner; F A Horster; H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

4.  Quantitative determination of praziquantel in body fluids by gas liquid chromatography.

Authors:  H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

  4 in total
  4 in total

1.  Serum concentrations and renal excretion in humans after oral administration of praziquantel--results of three determination methods.

Authors:  K Patzschke; J Pütter; L A Wegner; F A Horster; H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Quantitative studies on the occurrence of praziquantel in milk and plasma of lactating women.

Authors:  J Pütter; F Held
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

3.  Quantitative determination of praziquantel in body fluids by gas liquid chromatography.

Authors:  H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

4.  Spectrofluorimetric determination of oxamniquine in dosage forms and spiked human plasma through derivatization with 1-dimethylaminonaphthalene-5-sulphonyl chloride.

Authors:  N El-Enany; F Belal; M Rizk
Journal:  J Fluoresc       Date:  2007-12-05       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.